- Report
- June 2024
- 200 Pages
Global
From €6935EUR$7,950USD£6,039GBP
- Report
- June 2023
- 200 Pages
Global
From €6542EUR$7,500USD£5,698GBP
- Report
- April 2023
- 240 Pages
Global
From €3053EUR$3,500USD£2,659GBP
- Report
- December 2024
- 152 Pages
Global
From €3446EUR$3,950USD£3,001GBP
- Report
- February 2024
- 110 Pages
Global
From €4143EUR$4,750USD£3,609GBP
- Report
- April 2023
- 115 Pages
Global
From €4143EUR$4,750USD£3,609GBP
- Report
- April 2023
- 160 Pages
Global
From €4317EUR$4,949USD£3,760GBP
- Report
- October 2024
- 140 Pages
Global
From €2181EUR$2,500USD£1,899GBP
- Report
- April 2023
- 116 Pages
Global
From €3925EUR$4,500USD£3,419GBP
- Report
- January 2025
- 105 Pages
Global
From €3500EUR$4,298USD£3,155GBP
- Report
- December 2024
- 70 Pages
Global
From €3485EUR$3,995USD£3,035GBP
- Report
- October 2022
- 81 Pages
Global
From €3049EUR$3,495USD£2,655GBP
- Report
- August 2024
- 133 Pages
China
From €1570EUR$1,800USD£1,367GBP
- Report
- August 2024
- 101 Pages
China
From €1570EUR$1,800USD£1,367GBP
- Report
- January 2024
- 109 Pages
United States
€3053EUR$3,500USD£2,659GBP
- Report
- February 2018
- 680 Pages
Global
From €19190EUR$22,000USD£16,713GBP
- Report
- October 2023
- 101 Pages
Global
From €3500EUR$4,298USD£3,155GBP
- Report
- August 2023
- 94 Pages
Global
From €3500EUR$4,298USD£3,155GBP
- Report
- October 2024
- 90 Pages
Global
From €3500EUR$4,298USD£3,155GBP
- Report
- May 2023
- 94 Pages
Global
From €3500EUR$4,298USD£3,155GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more